Prevalence of metabolic syndrome in beta-thalassemia major adult patients in Tanta University Hospitals
Keywords:
β-thalassemia major, metabolic syndrome, prevalence, insulin resistanceAbstract
Introduction: one of long-term complications of Beta-thalassemia major (β-TM) disease is metabolic syndrome, which has a significant influence on patients' quality of life. Objective: to investigate the prevalence of metabolic syndrome in β-thalassemia major patients in Tanta University Hospitals. Materials and methods: our study included two groups. Group I: consist of (100) adult beta-thalassemia major patients. Group II: consist of (100) sex and age matched healthy subjects as control group. Results: the present study revealed that 29% of our β-thalassemia major patients had metabolic syndrome while in control group it was 2.0%, and low high-density lipoprotein (HDL)was the most frequent positive criterion it was 86.0% in β-thalassemia major patients' group. Prevalence of hyperglycemia, abdominal obesity, hypertriglyceridemia, and hypertension in patients with thalassemia was 29, 41, 21and 7%, respectively. Prevalence of metabolic syndrome in female patient was 34.3% while in male beta thalassemia major patient it was 18.2%. the prevalence of metabolic syndrome in well chelated beta thalassemia major patient was 0.0%, while in poorly chelated patients it was 35.4%. Conclusions: this study revealed that 29% of β-thalassemia major group patients had International Diabetes Federation (IDF) criteria of metabolic syndrome and low HDL was the most frequent positive criterion.
Downloads
References
Abdulsada, S. H., Farag, A. H., Kamil, H., Abdul-Rudha, S., & Hussein, A. A. (2017). Metabolic syndrome in Iraqi female patients with major β-thalassemia. MJS, 27(4), 78-98. doi:10.23851/mjs.v27i4.23
AESSOPOS, A., & FARMAKIS, D. (2005). Pulmonary Hypertension in β-Thalassemia. Annals of the New York Academy of Sciences, 1054(1), 342-349. doi:https://doi.org/10.1196/annals.1345.041
Asadi-Pooya, A. A., & Karamifar, H. (2004). Body mass index in children with beta-thalassemia major. Turk J Haematol, 21(4), 177-180.
Ayyash, H., & Sirdah, M. (2018). Hematological and biochemical evaluation of β-thalassemia major (βTM) patients in Gaza Strip: A cross-sectional study. Int J Health Sci (Qassim), 12(6), 18-24.
Bhat, K., & Periasamy, P. (2014). Effect of Long-Term Transfusion Therapy on the Glycometabolic Status and Pancreatic Beta Cell Function in Patients with Beta Thalassemia Major. J Family Med Prim Care, 3, 119-123. doi:10.4103/2249-4863.137621
Datz, C., Felder, T. K., Niederseer, D., & Aigner, E. (2013). Iron homeostasis in the metabolic syndrome. Eur J Clin Invest, 43(2), 215-224. doi:10.1111/eci.12032
El-Beshlawy, A., Kaddah, N., Rageb, L., Hussein, I., Mouktar, G., Moustafa, A., . . . El-Sendiony, H. (1999). Thalassemia prevalence and status in Egypt. Pediatr Res, 45(5), 760-770.
el-Hashemite, N., Petrou, M., Khalifa, A. S., Heshmat, N. M., Rady, M. S., & Delhanty, J. D. (1997). Identification of novel Asian Indian and Japanese mutations causing beta-thalassaemia in the Egyptian population. Hum Genet, 99(2), 271-274. doi:10.1007/s004390050352
Gozashti, M. H., Hasanzadeh, A., & Mashrouteh, M. (2014). Prevalence of metabolic syndrome in patients with minor beta thalassemia and its related factors: a cross-sectional study. J Diabetes Metab Disord, 13(1), 108-115. doi:10.1186/s40200-014-0108-z
Ismail, A., Campbell, M. J., Ibrahim, H. M., & Jones, G. L. (2006). Health related quality of life in malaysian children with thalassaemia. Health Qual Life Outcomes, 4, 39-45. doi:10.1186/1477-7525-4-39
Khalifa, A. S., Salem, M., Mounir, E., El-Tawil, M. M., El-Sawy, M., & Abd Al-Aziz, M. M. (2004). Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping. Pediatr Diabetes, 5(3), 126-132. doi:https://doi.org/10.1111/j.1399-543X.2004.00051.x
Loebstein, R., Lehotay, D. C., Luo, X., Bartfay, W., Tyler, B., & Sher, G. D. (1998). Diabetic nephropathy in hypertransfused patients with beta-thalassemia. The role of oxidative stress. Diabetes Care, 21(8), 1306-1309. doi:10.2337/diacare.21.8.1306
Maioli, M., Vigna, G. B., Tonolo, G., Brizzi, P., Ciccarese, M., Donegà, P., . . . Fellin, R. (1997). Plasma lipoprotein composition, apolipoprotein(a) concentration and isoforms in beta-thalassemia. Atherosclerosis, 131(1), 127-133. doi:10.1016/s0021-9150(97)06095-4
Martin, A., & Thompson, A. A. (2013). Thalassemias. Pediatr Clin North Am, 60(6), 1383-1391. doi:10.1016/j.pcl.2013.08.008
Olivieri, N. F., & Brittenham, G. M. (1997). Iron-chelating therapy and the treatment of thalassemia. Blood, 89(3), 739-761.
Pinto, V. M., & Forni, G. L. (2020). Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series. Int J Mol Sci, 21(22), 77-85. doi:10.3390/ijms21228771
Saki, F., Bahadori, R., Kashkooli, N. M., Jazayeri, A., Ghahremani, N., & Omrani, G. H. R. (2019). Prevalence of metabolic syndrome in beta thalassemia major adolescents in southern Iran: a cross-sectional study. Int J Diabetes Dev Ctries, 39(3), 444-450. doi:10.1007/s13410-018-0663-9
Shalev, H., Kapelushnik, J., Moser, A., Knobler, H., & Tamary, H. (2007). Hypocholesterolemia in chronic anemias with increased erythropoietic activity. Am J Hematol, 82(3), 199-202. doi:10.1002/ajh.20804
Shams, S., Ashtiani, M. T. H., Monajemzadeh, M., Koochakzadeh, L., Irani, H., Jafari, F., & Mohseni, A. (2010). Evaluation of serum insulin, glucose, lipid profile, and liver function in β-thalassemia major patients and their correlation with iron overload. Laboratory Medicine, 41(8), 486-489. doi:10.1309/lms0eoouzsii2bne
Suvarna, J., Ingle, H., & Deshmukh, C. T. (2006). Insulin resistance and beta cell function in chronically transfused patients of thalassemia major. Indian Pediatr, 43(5), 393-400.
Thuret, I., Pondarré, C., Loundou, A., Steschenko, D., Girot, R., Bachir, D., . . . Badens, C. (2010). Complications and treatment of patients with β-thalassemia in France: results of the National Registry. Haematologica, 95(5), 724-729. doi:10.3324/haematol.2009.018051
Weatherall, D. (2004). 2003 william allan award address. The thalassemias: The role of molecular genetics in an evolving global health problem. Am J Hum Genet, 74(3), 385-392. doi:10.1086/381402
Yamagishi, K., & Iso, H. (2017). The criteria for metabolic syndrome and the national health screening and education system in Japan. Epidemiol Health, 39, 170-178. doi:10.4178/epih.e2017003
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Rakhmonov, O. M., Shadmanov, A. K., & Juraev, F. M. (2021). Results of endoscopic treatment of benign prostatic hyperplasia in patients with metabolic syndrome. International Journal of Health & Medical Sciences, 5(1), 21-25. https://doi.org/10.21744/ijhms.v5n1.1811
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
